Lipid-lowering effectiveness of a Russian generic of atorvastatin in patients with various hyperlipidaemia phenotypes

Lipid-lowering effectiveness of a Russian generic of atorvastatin in patients with various hyperlipidaemia phenotypes

Aim. To assess lipid-lowering effectiveness of generic atorvastatin in patients with various hyperlipidaemia (HLP) phenotypes in an open, short-term (four weeks) study.Material and methods. All participants were divided into two groups — with isolated hypercholesterolemia (HCH) and normal fasting tr...

Full description

Saved in:

Bibliographic Details
Main Authors:	P. P. Malyshev, T. A. Rozhkova, Z. Yu. Malmakova, V. V. Kukharchuk
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2009-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atorvastatin hypertriglyceridemia hypercholesterolemia
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1479
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
by: A. N. Meshkov
Published: (2016-01-01)

EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY
by: A. V. Semenov, et al.
Published: (2016-01-01)

EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01)

Changes in Cardiovascular Risk Factors in Residents of the Siberian Region (According to Epidemiological Studies)
by: G. V. Artamonova, et al.
Published: (2021-07-01)

ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE
by: M. V. Solodun, et al.
Published: (2015-09-01)

SPECIFICS OF LIPID METABOLISM AND ATORVASTATIN EFFICACY IN TYPE 2 DIABETES WITH CARRIAGE OF VARIOUS POLYMORPHISMS OF CHOLESTEROL ETHER CARRYING PROTEIN TaqIB GENE
by: M. V. Kim, et al.
Published: (2015-10-01)

Lipid and pleiotropic effects of atorvastatin in patients with acute coronary syndrome
by: A. A. Yalymov, et al.
Published: (1970-01-01)

A case of rhabdomyolysis after atorvastatin therapy of a liver transplant recipient receiving immunosuppressive therapy with cyclosporine
by: A. V. Shabunin, et al.
Published: (2021-06-01)

ATORVASTATIN — 20 YEARS IN THE STRUGGLE FOR LIFE
by: N. G. Gogolashvili
Published: (2018-03-01)

Atorvastatin: evidence base 15 years later
by: A. V. Susekov, et al.
Published: (2011-06-01)

Phenotypical features of heterozygous familial hypercholesterolemia in individuals with LDLR or APOB gene mutations
by: A. N. Meshkov, et al.
Published: (1970-01-01)

Comparing efficacy of fibrates and statins in isolated and combined hypertriglyceridemia and various types of oxidative metabolism
by: G. S. Mal’
Published: (2005-06-01)

Lipid and pleiotropic effects of atorvastatin in patients with high cardiovascular risk
by: R. S. Karpov, et al.
Published: (2009-08-01)

Comparison of treatment patterns, efficacy and safety between generic and branded atorvastatin users in China: a multicenter, retrospective propensity score-matched cohort study
by: Xiaoxuan Xing, et al.
Published: (2025-07-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

Fabrication and evaluation of solidified nanoemulsion designs for systemic delivery of atorvastatin through the lung
by: Muhammad Danish Saeed, et al.
Published: (2025-07-01)

THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Familial defect of apolipoprotein В-100: molecular disease basis and clinico-biochemical characteristics of the patients
by: P. P. Malyshev, et al.
Published: (2007-12-01)

Statinotherapy – the paradigm of prevention and treatment of atherosclerotic pathology (focus on atorvastatin)
by: R. G. Oganov, et al.
Published: (2006-12-01)

EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY
by: E. A. Ushkalova, et al.
Published: (2016-06-01)

Aggressive statin therapy in acute coronary syndrome: therapeutic potential of atorvastatin in the daily dose of 80 mg
by: A. N. Britov
Published: (2009-12-01)

Russian extreme hypertriglyceridemia registy (REGGI): a call to action
by: U. V. Chubykina, et al.
Published: (2024-12-01)

Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome
by: Sh. A. Mostafa, et al.
Published: (2018-11-01)

Skin manifestations of secondary dyslipidemia: a case report
by: Z. F. Kim, et al.
Published: (2022-09-01)

ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING
by: A. V. Panov, et al.
Published: (2017-07-01)

EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE
by: G. A. Batrak, et al.
Published: (2015-09-01)

Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy
by: A. D. Gavrilko, et al.
Published: (2023-11-01)

Conservative therapy of epidural hematoma with atorvastatin combined with glucocorticoids: cases report and literature review
by: Chenrui Wu, et al.
Published: (2025-04-01)

Synthesis, characterization and Molecular docking simulation of novel Atorvastatin Aspirin ester, and study activation effect on lactate dehydrogenase enzyme in atherosclerosis patient
by: Asmaa Ghazi Shukr Al-ajeely, et al.
Published: (2025-08-01)

Identification and treatment of patients with high cardiovascular risk
by: I. V. Sergienko, et al.
Published: (1970-01-01)

Combined lipid lowering therapy, including ezetimibe, in the post-infarction period
by: V. E. Oleynikov, et al.
Published: (2024-05-01)

RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE
by: M. V. Ezhov
Published: (2016-01-01)

Age and gender characteristics of dyslipidemia prevalence among the Bishkek city residents
by: T. M. Murataliev, et al.
Published: (2019-04-01)

Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease
by: O. A. Rubanenko
Published: (2015-11-01)

Effect of Probucol and Atorvastatin Treatment on the Self‐Care Ability of Acute Cerebral Infarction Patients: A Randomized Clinical Trial Study
by: Ning Yu, et al.
Published: (2025-05-01)

Association of ABCB1 G2677T polymorphism with atorvastatin lipid efficacy and extended prognosis in patients with cerebral ischemic stroke
by: Yingna Tian, et al.
Published: (2025-08-01)

Development and validation of RP-HPLC method for determination of Atorvastatin calcium and Nicotinic acid in combined tablet dosage form
by: Jaiprakash N. Sangshetti, et al.
Published: (2016-09-01)

Arterial hypertension severity and blood lipid profile in thyrotoxicosis and hypothyrosis
by: P. Kh. Dzhanashiya, et al.
Published: (2004-08-01)

Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY)
by: S. Yu. Martsevich, et al.
Published: (2020-11-01)

Safety of Lipid-Lowering Therapy with Statins according to a Regional Pharmacovigilance Centre
by: E. O. Kochkina, et al.
Published: (2023-09-01)